Letters Section Editor: Robert M. Golub, MD, Senior Editor.
To the Editor: In their Review of neonatal signs after late in utero exposure to SSRIs, Dr Moses-Kolko and colleagues1 discussed 13 case reports that described 18 cases of neonatal exposure. We have published a report of 3 cases of neonatal fluoxetine withdrawal secondary to maternal use during pregnancy, which we would like to add to those cited in the Review.2
Lavenstein B. Neonatal Signs After In Utero Exposure to Selective Serotonin Reuptake Inhibitors. JAMA. 2005;294(18):2299-2301. doi:10.1001/jama.294.18.2300-a